Archive for 'Tag Archives: 'vaccines''
ImCyse plans first-in-human-therapy(FIHT) with disease-modifying vaccine to treat multiple sclerosis
Belgian-based ImCyse, a spin-off originally from the Catholic University of Leuven (KUL), but now established at both KUL and University of Liège (ULg), was founded in July 2010 by Prof. Jean-Marie Saint-Remy to valorize discoveries made [...]
Now hiring! Quality Assistance (QA), a contract research organization (CRO) dedicated to 3rd generation medicines, has announced a €4.5 million investment over the next 18 months and a commitment to creating 15 new jobs by the [...]
In March, GlaxoSmithKline(GSK) and the Texas A&M University System (TAMUS) announced the U.S. Department of Health and Human Services (DHHS) had approved the establishment of a $91 million (€70.3 million) influenza-vaccine manufacturing facility as the pillar [...]